Pozelimab for CHAPLE disease: results from in-trial interviews and clinical outcome assessments.
Litcher-Kelly L, Ozen A, Ollis S, Feldman HB, Yaworsky A, Medrano P, Chongsrisawa V, Brackin T, Perlee L, Walker M, Pradeep S, Lenardo MJ, Harari OA, Jalbert JJ.
Litcher-Kelly L, et al. Among authors: pradeep s.
Orphanet J Rare Dis. 2024 Aug 8;19(1):290. doi: 10.1186/s13023-024-03277-9.
Orphanet J Rare Dis. 2024.
PMID: 39118150
Free PMC article.